FDA approves cablivi for rare blood-clotting disorder

FDA Approves Cablivi For Rare Blood Clotting Disorder essay is one as concers the Health and Medical Updates categories, posted at our publisher Linda Norton just as February 7, 2019, those article maybe want to search just after these tags approves, Bloodclotting, cablivi, disorder, FDA, rare. I am pleasant to glad you along with providing those anothers paper like health also I always updating the post daily.

Fdaapprovesc.jpg

(HealthDay)—Cablivi (caplacizumab-yhdp) injection has been approved by the U.S. Food and Drug Administration to treat adults with acquired thrombotic thrombocytopenic purpura (aTTP).

“Patients with aTTP endure hours of treatment with daily plasma exchange, which requires being attached to a machine that takes blood out of the body and mixes it with donated plasma and then returns it to the body,” Richard Pazdur, M.D., director of the FDA Oncology Center of Excellence, said in a statement. “Even after days or weeks of this treatment, as well as taking drugs that suppress the immune system, many patients will have a recurrence of aTTP.”

Cablivi is the first targeted treatment that inhibits blood clot formation and provides a new treatment option for patients that may reduce recurrences. Cablivi was evaluated in clinical studies involving 145 people. Those treated with Cablivi had fewer instances of aTTP-related death, the FDA said.

Common side effects include headache and bleeding of the nose or gums. Cablivi’s prescribing information includes a warning about the risk for severe bleeding. Health care providers should closely monitor patients who also take anticoagulants, the FDA said.

The drug is produced by Ablynx, based in Belgium.


FDA approves novel treatment for hairy cell leukemia


More information:
More Information

Health News Copyright © 2019 HealthDay. All rights reserved.

Citation:
FDA approves cablivi for rare blood-clotting disorder (2019, February 7)
retrieved 7 February 2019
from https://medicalxpress.com/news/2019-02-fda-cablivi-rare-blood-clotting-disorder.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

You probably want to view other blogpost health over our similar section or you probably want to check it just after noted post, I'm always updating these health essay routine for suggest plus hint together with trick that one may controling our health moreover living those healthy lifestyle. These paragraph is published on top of Linda Norton with this title FDA Approves Cablivi For Rare Blood Clotting Disorder.

Related posts of "FDA approves cablivi for rare blood-clotting disorder"

Eating breakfast could be the reason your diet isn’t working

Researchers at Monash University in Australia say that eating breakfast as part of a weight loss strategy may not be as beneficial as dieters are led to believe. Foxys Forest Manufacture | Shutterstock Research has previously suggested that including breakfast in your daily diet can supply energy, ramp up metabolism and help to prevent snacking...

Scientists shed light on processes behind age-related decline in brain structures important for memory

Credit: CC0 Public Domain Ageing can cause damage to support cells in the white matter, which in turn may lead to damage in the grey matter of the hippocampus, finds a new study by Cardiff University. The discovery gives researchers a new area to focus on in the search for treatments that can protect cognitive...

RNAs play key role in protein aggregation and in neurodegenerative disease, according to new research

Credit: CC0 Public Domain New research reveals RNAs, which are crucial for cells to produce proteins, are also involved in protein aggregation, where proteins do not fold properly and 'clump' together into aggregates. If cells cannot clear these away, they become toxic and prevent cells working properly. This discovery, led by scientists at the Centre...

Men who are able to do ten push-ups are less likely to have a stroke

A new study has found a link between the number of push-ups a person is able to do and the risk of cardiovascular disease. The findings show that middle-aged men who are able to complete 10 push-ups could reduce their risk of heart attack and stroke by as much as 97 percent. g-stockstudio | Shutterstock...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.